To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Inhibrx secures $10m credit facility from Oxford
Oxford Finance LLC has provided a $10 million credit facility to Inhibrx Inc, a clinical-stage biotechnology company.
